semaglutide vs tirzepatide for inflammation vs. Weight Loss Semaglutide/Tirzepatide: Beyond Weight Loss: Shamsah

Its the difference between a linear study and one that explores exponential potential

Presented for research literature review only Coccurello R et al

Preliminary data from a phase 1b extension study (NCT05292911) involving 64 individuals with MRI-PDFF 10% and BMI 28 kg/m 2 demonstrated that 50%, 44%, and 60% of participants presenting baseline alanine aminotransferase (ALT) 30 IU/L reached combined MRI-PDFF reduction 30% and ALT reduction 17 IU/L at pemvidutide doses of 1.2, 1.8, and 2.4 mg, respectively, vs

Readers interested in the broader topic of how lifestyle impacts health can explore how lifestyle choices impact overall health

Factors like weight, tolerance, and existing medical conditions impact the dose